Additionally, reduction in albuminuria does not occur in all patients treated with SGLT2 inhibitors, with a reporting that 42.3 % of patients with diabetes failed to show a decrease in UACR despite treatment [22]. This evidence concerns the gene SLC5A2 and diabetes mellitus.